Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bio-Techne Cp (TECH)

Bio-Techne Cp (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,239,316
  • Shares Outstanding, K 38,799
  • Annual Sales, $ 738,690 K
  • Annual Income, $ 229,300 K
  • 60-Month Beta 1.11
  • Price/Sales 21.81
  • Price/Cash Flow 67.53
  • Price/Book 10.47
Trade TECH with:

Options Overview

Details
  • Implied Volatility 32.05%
  • Historical Volatility 34.50%
  • IV Percentile 38%
  • IV Rank 36.32%
  • IV High 44.40% on 04/21/20
  • IV Low 25.01% on 12/18/20
  • Put/Call Vol Ratio 7.76
  • Today's Volume 149
  • Volume Avg (30-Day) 71
  • Put/Call OI Ratio 1.31
  • Today's Open Interest 1,667
  • Open Int (30-Day) 349

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 1.24
  • Number of Estimates 3
  • High Estimate 1.34
  • Low Estimate 1.17
  • Prior Year 1.22
  • Growth Rate Est. (year over year) +1.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
357.19 +17.18%
on 03/25/21
423.09 -1.07%
on 04/14/21
+30.18 (+7.77%)
since 03/16/21
3-Month
311.03 +34.57%
on 01/28/21
423.09 -1.07%
on 04/14/21
+70.84 (+20.37%)
since 01/15/21
52-Week
200.09 +109.18%
on 04/21/20
423.09 -1.07%
on 04/14/21
+206.57 (+97.45%)
since 04/16/20

Most Recent Stories

More News
Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand...

TECH : 418.55 (+0.81%)
Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing...

TECH : 418.55 (+0.81%)
QGEN vs. TECH: Which Stock Should Value Investors Buy Now?

QGEN vs. TECH: Which Stock Is the Better Value Option?

QGEN : 52.75 (+0.11%)
TECH : 418.55 (+0.81%)
Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western...

TECH : 418.55 (+0.81%)
Bio-Techne Completes Acquisition of Asuragen, Inc.

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.  The transaction included initial consideration of in cash plus contingent...

TECH : 418.55 (+0.81%)
Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on , at to review third quarter 2021 financial results.

TECH : 418.55 (+0.81%)
Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of Cultrex™ UltiMatrix™ Reduced Growth Factor Basement Membrane Extract (RGF BME), an extracellular matrix hydrogel...

TECH : 418.55 (+0.81%)
Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its R&D Systems and Novus brands have been named winners of the CiteAb COVID-19 Innovation Award.  This award celebrates...

TECH : 418.55 (+0.81%)
Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed its clinical validation of an in vitro diagnostic (IVD) version of the...

TECH : 418.55 (+0.81%)
Bio-Techne Announces ISO 9001:2015 Certification for its Bristol Manufacturing Facility.

, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced...

TECH : 418.55 (+0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 429.27
2nd Resistance Point 424.52
1st Resistance Point 421.54
Last Price 418.55
1st Support Level 413.81
2nd Support Level 409.06
3rd Support Level 406.08

See More

52-Week High 423.09
Last Price 418.55
Fibonacci 61.8% 337.90
Fibonacci 50% 311.59
Fibonacci 38.2% 285.28
52-Week Low 200.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar